Clinical trial
Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or…
NCT00459524 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00459524 |
|---|---|
| Title | Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) |
| Official title | Longitudinal Assessment of Neurocognitive Function and Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) Undergoing Treatment |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Acute Myelogenous Leukemia, Myelodysplastic Syndrome |
| Intervention type | Behavioral |
| Interventions | Questionnaire, Neurocognitive Testing |
| Enrollment | 104 |
| Start date | Apr 1, 2004 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Apr 12, 2007 |
| Last update posted | Aug 1, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: